Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from CSL Behring and Takeda, Inc.

Clinical Briefings™: Promoting Excellence in the Care Of von Willebrand Disease

Release Date: June 15, 2020
Expiration Date: June 15, 2021

Activity Overview

This online activity is designed to provide a concise and focused overview of the complex pathophysiology of von Willebrand disease (VWD), the clinical presentation and diagnostic evaluation of patients with this disorder, and the efficacy and safety of therapies recommended for the management of VWD. The multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgement of Commercial Support

This activity is supported by educational grants from CSL Behring and Takeda, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed toward hematologists, primary care physicians, and other healthcare professionals involved in VWD care, such as nurse practitioners and physician assistants.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Discuss the epidemiology, etiology, and genotypic/phenotypic presentation of VWD
  • Recognize VWD phenotyping utilizing clinical assessment measures and laboratory testing, including the vWf:RCo/vWf:Ag ratio
  • Evaluate the efficacy, safety, and dosing/administration of currently approved therapies for patients with VWD

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Craig M. Kessler, MD, MACP
Craig M. Kessler, MD, MACP
Professor of Medicine and Pathology
Director, Division of Coagulation
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, DC

Disclosures: Grant/Research Support: Octapharma, Takeda; Consultant: CSL Behring, Octapharma, Takeda; Other Support: Director, 340B program at HTC.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By